Critical appraisal:Walker J, Hansen CH, Martin P, Symeonides S, Gourley C, Wall L, et al 2014
Critical Appraisal
Walker J, Hansen CH, Martin P, Symeonides S, Gourley C, Wall L, et al. Integrated collaborative care for major depression comorbid with a poor prognosis cancer (SMaRT Oncology-3): a multicentre randomised controlled trial in patients with lung cancer. Lancet Oncol 2014 Sep;15(10):1168-76 Available from: http://www.ncbi.nlm.nih.gov/pubmed/25175097.
Key Facts
randomised controlled trial
The study aimed to assess whether an integrated treatment programme for major depression was more effective than treatment as usual in treating depression in patients with lung cancer.
142
Most (81%) of the participants who were allocated to the intervention group received at least four treatment sessions.
Average depression severity was significantly lower in patients in the intervention group than in those in the usual care group.
Self-rated depression, anxiety, quality of life, role functioning, perceived quality of care, and proportion of patients achieving a 12-week treatment response were also significantly better in the intervention group versus the usual care group.
no
Evidence ratings
II
Low risk of bias | Comments: Trial statisticians and staff who collected outcomes where masked, however participants and clinicians were not. |
1 | Reason for decision: depression severity was significantly lower in patients allocated to the intervention group. Anxiety quality of life were also significantly better in the intervention group compared to the treatment as usual group. |
1 | Additional comments: The study focused on depression outcomes for people with lung cancer |
- Article
- Walker J, Hansen CH, Martin P, Symeonides S, Gourley C, Wall L, et al. Integrated collaborative care for major depression comorbid with a poor prognosis cancer (SMaRT Oncology-3): a multicentre randomised controlled trial in patients with lung cancer. Lancet Oncol 2014 Sep;15(10):1168-76 Available from: http://www.ncbi.nlm.nih.gov/pubmed/25175097.
- Assigned to
- User:Maria.ftanou
- Topic area
- Guidelines:Lung cancer/Treatment/Non-small-cell stage IV inoperable
- Clinical question
Section below only relevant for Cancer Council Project Officer